Ultrastructural observations in Parkinsonism

scientific article published in September 1969

Ultrastructural observations in Parkinsonism is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/PATH.1710990106
P953full work available at URLhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpath.1710990106
https://onlinelibrary.wiley.com/doi/full/10.1002/path.1710990106
P698PubMed publication ID5359222

P2093author name stringRoy S
Wolman L
P2860cites workThe use of lead citrate at high pH as an electron-opaque stain in electron microscopyQ26778439
The brain-stem lesions in ParkinsonismQ37272987
A study of fixation for electron microscopyQ42971380
Studies on Parkinson's Disease Including X-Ray Fluorescent Spectroscopy of Formalin Fixed Brain TissueQ44740772
Progressive familial myoclonic epilepsy with Lafora bodies. Electron microscopic and histochemical study of a cerebral biopsy.Q51218771
LAFORA'S DISEASE. DISTINCT CLINICO-PATHOLOGIC FORM OF UNVERRICHT'S SYNDROME.Q51257115
ULTRASTRUCTURE OF CORPORA AMYLACEAQ51260584
ELECTRON MICROSCOPIC OBSERVATIONS ON THE HUMAN SUBSTANTIA NIGRA.Q51274162
Concentric hyaline inclusion body formation in mental disease analysis of twenty-seven cases.Q51294103
Ultrastructure of Lafora bodiesQ72183170
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectParkinson's diseaseQ11085
P304page(s)39-44
P577publication date1969-09-01
P1433published inJournal of PathologyQ400296
P1476titleUltrastructural observations in Parkinsonism
P478volume99

Reverse relations

cites work (P2860)
Q48822801A comparison of autofluorescence emission spectra of bleached neuromelanin in non-diseased substantia nigra with spectra of other intraneuronal pigments in non-diseased and diseased tissue
Q36425805A new type of inclusion body in human spinal cord
Q34989985A53T human α-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration
Q48352469An early cytoplasmic change before Lewy body maturation: an ultrastructural study of the substantia nigra from an autopsy case of juvenile parkinsonism
Q48708845An ultrastructural study of the synaptic densities, nematosomes, neurotubules, neurofilaments and of a further three-dimensional filamentous network as disclosed by the E-PTA staining procedure
Q28472271C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging
Q90240136Cell models of lipid-rich α-synuclein aggregation validate known modifiers of α-synuclein biology and identify stearoyl-CoA desaturase
Q48620412Classic and generalized variants of Pick's disease: A clinicopathological, ultrastructural, and immunocytochemical comparative study
Q48852737Cortical changes in the parkinsonian brain: a contribution to the delineation of "diffuse Lewy body disease".
Q33894382Critical role of truncated α-synuclein and aggregates in Parkinson's disease and incidental Lewy body disease
Q40095790Dense core vesicles around the Lewy body in incidental Parkinson's disease: an electron microscopic study
Q48299267Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies
Q44802800Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP.
Q41863606Filaments of Lewy bodies contain insoluble cytoskeletal elements
Q39503766Idiopathic Parkinson's disease and the Lewy body disorders
Q40137936Idiopathic parkinsonism with lewy-type inclusions in cerebral cortex. A case report
Q44016007Immunocytochemical localization of synaptic vesicle-specific protein in lewy body-containing neurons in Parkinson's disease
Q36492162Inhibitors of alpha-synuclein oligomerization and toxicity: a future therapeutic strategy for Parkinson's disease and related disorders
Q48738928Lewy Bodies of Parkinson's Disease Contain Neurofilament Antigens
Q34478663Lewy bodies
Q34263455Lewy bodies in cerebral cortex, report of three cases
Q92104903Lipids as Trans-Acting Effectors for α-Synuclein in the Pathogenesis of Parkinson's Disease
Q41663203Lipofuscin in the cerebellar cortex of albino rats: An electron microscopic study
Q47801119Loss of native α-synuclein multimerization by strategically mutating its amphipathic helix causes abnormal vesicle interactions in neuronal cells
Q44212285Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease
Q47300849Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62.
Q67914362Neuronal inclusions of Parkinson's disease
Q58216347New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies
Q24597726PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease
Q50532472Pale neurites, premature α-synuclein aggregates with centripetal extension from axon collaterals.
Q49135439Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathies
Q92465171Parkinson's disease: proteinopathy or lipidopathy?
Q69846956Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses
Q55347683Parkinsonism-physiology and pharmacology.
Q34842740Presenile dementia with Alzheimer-, Pick- and Lewy-body changes
Q36319183Radiating amyloid fibril formation on the surface of lipid membranes through unit-assembly of oligomeric species of α-synuclein
Q36333500Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson's disease patients.
Q51109441Ultrastructural studies of the nervous system after mercury intoxication. I. Pathological changes in the nerve cell bodies.
Q70153354Ultrastructural study of corpora amylacea in human thyroid gland
Q39987734Ultrastructure of Lewy bodies in the stellate ganglion
Q24653247alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

Search more.